Non-follicular lymphoma, unspecified, affecting extranodal and solid organ sites, represents a group of hematological malignancies characterized by the proliferation of lymphoid tissue outside of lymph nodes. This condition is clinically significant due to its potential for aggressive behavior and varied presentation. Accurate coding with ICD-10 Code C83.99 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C83.99 designates Non-follicular lymphoma, unspecified, affecting extranodal and solid organ sites. This code is used when the specific type of non-follicular lymphoma is not identified, yet the disease is confirmed to involve areas outside the lymphatic system. It is crucial for clinical documentation and billing when a patient presents with symptoms indicative of this malignancy, ensuring appropriate treatment and resource allocation.
Non-follicular lymphoma, unspecified, affecting extranodal and solid organ sites, is a type of lymphoma that arises from lymphoid tissue outside of the lymph nodes. The etiology may involve genetic mutations, environmental factors, or immune system dysregulation. This condition can progress rapidly, necessitating prompt medical evaluation and intervention.
ICD-10 Code C83.99 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment plan for patients with Non-follicular lymphoma. It plays a vital role in capturing the patient's symptoms, guiding clinical assessments, and informing treatment strategies in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C83.99 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Non-follicular lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Non-follicular lymphoma, unspecified, affecting extranodal and solid organ sites often requires hospitalization due to the potential for rapid disease progression. Treatment approaches may include chemotherapy, radiation therapy, or targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.99 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 77014 | Radiologic guidance for placement of a catheter or needle. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C83.99 for Non-follic lymphoma, unsp, extrnod and solid organ sites
What are the common symptoms of Non-follic lymphoma?
Common symptoms include unexplained weight loss, persistent fever, night sweats, and lymphadenopathy. Patients may also experience fatigue and abdominal discomfort due to organ involvement.
How is Non-follic lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected tissues. Laboratory tests may also be conducted to assess overall health and disease markers.
What treatment options are available for Non-follic lymphoma?
Treatment options may include chemotherapy, radiation therapy, and targeted therapies. Supportive care is also essential to manage symptoms and improve quality of life.
Is Non-follic lymphoma contagious?
No, Non-follic lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and is not transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes